Concepedia

Haifan Xu

HX

Statistics

Publications

10

Citations

551

H-Index

10

Active since

2014

Affiliations

University of South China(Current)

First Affiliated Hospital of University of South China

Xiangya Hospital Central South University

Central South University

Hunan Cancer Hospital

Haifan Xu is an author at University of South China specializing in medicine, oncology, and molecular oncology.

Publications per year

2014–2022

10

Publications

10

U6 is not a suitable endogenous control for the quantification of circulating microRNAs

Ying Zeng, Ruirui Yang, Haifan Xu et al. · Biochemical and Biophysical Research Communications · 2014 · 267 citations

Life Sciences, Molecular Biology, Molecular Medicine +6

Serum miR-20a is a promising biomarker for gastric cancer

Ruirui Yang, Yun Fu, Ying Zeng et al. · Biomedical Reports · 2017 · 65 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Hypoxia regulates stemness of breast cancer MDA-MB-231 cells

Jing Xie, Yong Xiao, Zhouyu Ning et al. · Medical Oncology · 2016 · 53 citations · Full text

Medicine, Cell Biology, Oncology +17

Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway

Fengbo Tan, Hong‐Jian Zhu, Yiming Tao et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +17

Therapeutic activity of DCC‐2036, a novel tyrosine kinase inhibitor, against triple‐negative breast cancer patient‐derived xenografts by targeting AXL/MET

Yingying Shen, Wei Zhang, Jianghua Liu et al. · International Journal of Cancer · 2018 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 10